Primary Care Diabetes
Volume 3, Issue 1 , Pages 29-35 , February 2009

How are we diagnosing cardiometabolic risk in primary care settings?

Received 21 November 2007 ,Revised 6 November 2008 ,Accepted 11 December 2008.

References 

  1. Ogden CI, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555
  2. Mensah GA, Mokdad AH, Ford E, et al. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol. Clin. 2004;22:485–514
  3. Olshansky SJ, Passaro DJ, Hewshow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 2005;352:1138–1145
  4. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–2000
  5. Wilson PW, D’Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–3072
  6. McLaughlin T, Abbast F, Lamendola C, Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals. Arch. Intern. Med. 2007;167:642–648
  7. Rosenzweig JL, Ferannini E, Grundy SM, et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2008;93(10):3671–3689
  8. Reaven GM. The metabolic syndrome: is this diagnosis necessary?. Am. J. Clin. Nutr. 2006;83:1237–1247
  9. Ruige JB, Mertens I, Bartholomeeusen E, et al. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. Obesity. 2006;14:1250–1256
  10. American Diabetes Association . Standards of medical in diabetes – 2008. Diabetes Care. 2008;31(Suppl. 1):S12–S54
  11. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143–3421.
  12. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;25(112):2735–2752
  13. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30:8–13
  14. Galassi A, Reynolds K, He J. Metabolic syndrome and the risk of cardiovascular disease: a meta-analysis. Am. J. Med. 2006;119:812–819
  15. Mitka M. Does the metabolic syndrome really exist? Diabetes and heart groups spar over issue. JAMA. 2005;294:2010–2013
  16. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J. Am. Coll. Cardiol. 2006;47:1093–1100
  17. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter?. Circulation. 2007;115:1806–1811
  18. Trowbridge FL, Sofka D, Holt K, Barlow SE. Management of child and adolescent obesity: study design and practitioner characteristics. Pediatrics. 2002;110:205–209
  19. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J. Clin. Epidemiol. 1997;50(10):1129–1136
  20. Foster GD, Wadden TA, Makris AP, et al. Primary care physicians’ attitudes about obesity and its treatment. Obes. Res. 2003;11:1168–1177
  21. Billington CJ. The challenge of obesity management in primary care. J. Am. Board Fam. Pract. 2000;13:222–223
  22. Huang J, Yu H, Marin E, et al. Physician weight loss counseling in two public hospital primary care clinics. Acad. Med. 2004;79:156–161
  23. O’Connor PJ, Gregg E, Rush WA, et al. Diabetes: how are we diagnosing and initially managing it?. Ann. Fam. Med. 2006;4:15–22
  24. Borai A, Livingstone C, Ferns GA. The biochemical assessment of insulin resistance. Ann. Clin. Biochem. 2007;44:324–342
  25. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006;55:1537–1548
  26. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346(6):393–403
  27. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–1679
  28. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006;113:2943–2946

PII: S1751-9918(08)00135-6

doi: 10.1016/j.pcd.2008.12.002

Primary Care Diabetes
Volume 3, Issue 1 , Pages 29-35 , February 2009

Article Tools